Pancreatic Cancer Research

ResearcherWuhan Union HospitalActive in the last 2 years

Tao Yin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6553-8969; OpenAlex author ID A5126622031. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. NCLX Inhibition plus Ca2+ Delivery Potentiates Electroporation and Antitumor Immunity in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1002/advs.78288↗
  2. Disruption of iron homeostasis sensitizes pancreatic cancer to irreversible electroporation. Co-author DOI 10.1038/s41467-026-68585-z↗
  3. Follicular pancreatitis mimicking pancreatic cancer: A diagnostic challenge. Last author DOI 10.1016/j.gastre.2025.502463↗
  4. USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2. Co-author DOI 10.1016/j.biopha.2023.115359↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yu Lu · 1 shared paper, 2025 · strength 0.42
  2. Chuanbing Zhao · 1 shared paper, 2026 · strength 0.32
  3. Linrong Li · 1 shared paper, 2026 · strength 0.30
  4. Jun Zhao · 1 shared paper, 2026 · strength 0.30
  5. Xin Long · 1 shared paper, 2026 · strength 0.30
  6. Yao Guo · 1 shared paper, 2023 · strength 0.19
  7. Jing Cui · 1 shared paper, 2023 · strength 0.19
  8. Tao Peng · 1 shared paper, 2023 · strength 0.19
  9. Shanmiao Gou · 1 shared paper, 2023 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.